A study using HSV-1 as a treatment for melanoma reported the characteristics of HSV-1 (herpes simplex virus 1) that recognizes herpesvirus entry mediator (HVEM) overexpressed on the surface of melanoma tumor cells as receptors [49]. This evidence concerns the gene TNFRSF14 and melanoma.